This roundtable, recorded on March 26, 2021, features an international panel of leading experts discussing COVID-19: how it began, where we are now, and their predictions for the future. They ask – did we make the right calls early on? Are we making the right calls now? Is our testing adequate? How are our vaccines performing? They emphasize the hard work of all involved in diagnostics, treatment, and vaccine development; laud the speed of science and medicine that has led to rapid advances; and discuss the future of COVID-19, including new variants, new approaches to disease control, and the wider impact of the pandemic.
The discussion was sponsored by Asuragen and SpeeDx.
Meet the Panel
Adrian Wildfire is Director of Scientific and Business Strategy at hVIVO and moderated the roundtable discussion
Peter Openshaw is Professor of Experimental Medicine at Imperial College London and a member of the government’s New and Emerging Respiratory Virus Threats Advisory Group
Rebecca Jane Cox is Professor of Medical Virology and head of the Influenza Centre at the University of Bergen and Haukeland University Hospital, Norway
Daniel Hoft is Professor of Internal Medicine at St. Louis University School of Medicine
Dennis Strenk is a Pathologists’ Assistant at Wisconsin Diagnostic Laboratories and host of the “People of Pathology” podcast.
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
